Literature DB >> 378353

Immunodiagnosis of mesothelioma: use of antimesothelial cell serum in an indirect immunofluorescence assay.

G Singh, T L Whiteside, A Dekker.   

Abstract

Cells isolated from human serous effusions were cultured in vitro. Monolayers of large multipolar cells were established. Antisera to the cultured cells were prepared in rabbits and rats. The antisera were absorbed with human red cells, liver powder and MOLT-4F cell line lymphocytes. Specificity of the absorbed antisera for human mesothelial cells were demonstrated in an indirect immunofluorescence assay. The antisera were used to confirm the diagnosis of mesothelioma in two cases. In both the patients, the morphologically identifiable malignant cell populations in the effusions stained positively with the antimesothelial cell serum thus establishing their mesothelial origin. Normal nonmesothelial tissue and known nonmesothelial tumors failed to react with the antisera thus confirming the specificity of the antisera.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 378353     DOI: 10.1002/1097-0142(197906)43:6<2288::aid-cncr2820430619>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  New marker for mesothelioma: an immunoperoxidase study.

Authors:  A Donna; P G Betta; D Bellingeri; A Marchesini
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

2.  Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies.

Authors:  A K Ghosh; A I Spriggs; J Taylor-Papadimitriou; D Y Mason
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

3.  Monoclonal antibodies to human malignant mesothelioma.

Authors:  T M Anderson; E C Holmes; C J Kosaka; L Cheng; R E Saxton
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

4.  The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance.

Authors:  G A Blobel; R Moll; W W Franke; K W Kayser; V E Gould
Journal:  Am J Pathol       Date:  1985-11       Impact factor: 4.307

5.  Immunohistochemical localization of prekeratin filaments in benign and malignant cells in effusions. Comparison with intermediate filament distribution by electron microscopy.

Authors:  H J Kahn; W Hanna; H Yeger; R Baumal
Journal:  Am J Pathol       Date:  1982-11       Impact factor: 4.307

6.  Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining.

Authors:  W S Kwee; R W Veldhuizen; R P Golding; H Mullink; J Stam; R Donner; M E Boon
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

7.  ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies.

Authors:  C J O'Hara; J M Corson; G S Pinkus; R A Stahel
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

8.  Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.

Authors:  I Lee; J A Radosevich; G Chejfec; Y X Ma; W H Warren; S T Rosen; V E Gould
Journal:  Am J Pathol       Date:  1986-06       Impact factor: 4.307

9.  Failure to demonstrate tumour-associated transplantation antigens on asbestos-induced mesotheliomas in rats.

Authors:  D G Brown; J C Wagner; M M Wagner
Journal:  Br J Cancer       Date:  1980-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.